Actively Recruiting
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
Led by Asociación Española para el Estudio del Hígado · Updated on 2025-01-10
5000
Participants Needed
1
Research Sites
778 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the registry is to know the status of primary biliary colgantis, autoimmune hepatitis, primary sclerosing cholagitis and genetic cholestatic diseases in Spain.
CONDITIONS
Official Title
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a confirmed diagnosis for primary biliary cholangitis, autoimmune hepatitis, primary sclerosing cholangitis, or genetic cholestatic disease
You will not qualify if you...
- Refusal to sign the informed consent for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clinic
Barcelona, Spain
Actively Recruiting
Research Team
A
Asociación Española para el Estudio del Hígado Asociación Espa
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here